Sunitinib in metastatic renal cell carcinoma (mRCC): preliminary assessment of safety and efficacy in an expanded access trial with subpopulation analysis

被引：16
|
作者：
Gore, M. [1 ]
Szczylik, C. [2 ]
Porta, C. [3 ]
Bracarda, S. [4 ]
Hawkins, R. [5 ]
Bjarnason, G. [6 ]
Oudard, S. [7 ]
Lee, S. H. [8 ]
Carteni, G. [9 ]
Eberhardt, W. [10 ]
机构：
[1] Royal Marsden Hosp NHS Trust, London, England
[2] Mil Inst Med, Warsaw, Poland
[3] Univ Hosp Fdn, IRCCS San Matteo, Pavia, Italy
[4] Aziendia Osped Perugia, Perugia, Italy
[5] Christie Hosp, Manchester, Lancs, England
[6] Toronto Sunnybrook Reg Canc Ctr, Toronto, ON, Canada
[7] Hop Europeen Georges Pompidou, Paris, France
[8] Seoul Natl Univ Hosp, Seoul, South Korea
[9] AORN A Cardarelli, Div Oncol, Naples, Italy
[10] Univ Duisburg Gesamthsch, Univ Hosp, W German Canc Ctr, Dept Internal Med, Essen, Germany
来源：
EJC SUPPLEMENTS | 2007年 / 5卷 / 04期
关键词：
D O I：
10.1016/S1359-6349(07)71134-5
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
4503
引用
收藏
页码：299 / 299
页数：1
相关论文
共 50 条
  • [1] Sunitinib in metastatic renal cell carcinoma (mRCC): Preliminary assessment of toxicity in an expanded access trial with subpopulation analysis
    Gore, M. E.
    Porta, C.
    Oudard, S.
    Bjarnason, G.
    Castellano, D.
    Szczylik, C.
    Mainwaring, P. N.
    Schoffski, P.
    Rini, B. I.
    Bukowski, R. M.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
  • [2] Safety and efficacy of sunitinib in metastatic renal cell carcinoma (mRCC): Preliminary assessment of an Italian expanded-access program (EAP) with subpopulation analysis
    Stemberg, Cora N.
    Porta, Camillo
    Bracarda, Sergio
    Carteni, Giacomo
    Lo Re, Giovanni
    Ruggeri, Enzo M.
    Conte, Pierfranco
    Monfardini, Silvio
    Gasparini, Giampietro
    Ciuffreda, Libero
    Marini, Giovanni
    Bonetti, Andrea
    Heouaine, Abdhelhamid
    Bernardini, Ilaria
    Ravaioli, Alberto
    Labianca, Roberto
    JOURNAL OF UROLOGY, 2008, 179 (04): : 418 - 418
  • [3] Safety and efficacy of sunitinib in an expanded-access trial of metastatic renal cell carcinoma (MRCC): Updated results and subpopulation analysis
    Oudard, S.
    Szczylik, C.
    Porta, C.
    Bracarda, S.
    Hawkins, R.
    Bjarnason, G.
    Lee, S. H.
    Carteni, G.
    Eberhardt, W.
    Gore, M.
    EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) : 246 - 246
  • [4] Updated Safety and Efficacy Results for Sunitinib From a Global, Expanded-Access Trial in Metastatic Renal Cell Carcinoma (mRCC)
    Gore, M.
    Porta, C.
    Bracarda, S.
    Crino, L.
    Hawkins, R.
    Bjarnason, G.
    Oudard, S.
    Lee, S. H.
    Kim, T. M.
    Szczylik, C.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S515 - S515
  • [5] Safety and efficacy of sunitinib for metastatic renal-cell carcinoma: an expanded-access trial
    Gore, Martin E.
    Szczylik, Cezary
    Porta, Camillo
    Bracarda, Sergio
    Bjarnason, Georg A.
    Oudard, Stephane
    Hariharan, Subramanian
    Lee, Se-Hoon
    Haanen, John
    Castellano, Daniel
    Vrdoljak, Eduard
    Schoffski, Patrick
    Mainwaring, Paul
    Nieto, Alejandra
    Yuan, Jinyu
    Bukowski, Ronald
    LANCET ONCOLOGY, 2009, 10 (08): : 757 - 763
  • [6] Subpopulation analysis from an ongoing expanded-access trial of Sunitinib in metastatic renal cell carcinoma
    Eberhardt, W.
    Weigang-Koehler, K.
    Gruenwald, V.
    Fiedler, W.
    Steiner, T.
    Stoeckle, M.
    Bergmann, L.
    Casper, J.
    Wirth, M. P.
    Gore, M. E.
    ONKOLOGIE, 2008, 31 : 179 - 179
  • [7] Short- and long-term safety with sunitinib in an expanded access trial in metastatic renal cell carcinoma (mRCC)
    Porta, C.
    Szczylik, C.
    Bracarda, S.
    Hawkins, R.
    Bjarnason, G. A.
    Oudard, S.
    Lee, S.
    Carteni, G.
    Hariharan, S.
    Gore, M. E.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [8] An Asian subpopulation analysis of the safety and efficacy of sunitinib in metastatic renal cell carcinoma
    Lee, S.
    Chung, H. C.
    Mainwaring, P.
    Ng, C.
    Chang, J. W. C.
    Kwong, P.
    Li, R. K.
    Sriuranpong, V.
    Toh, C. K.
    Lowenthal, S. Pitman
    EJC SUPPLEMENTS, 2009, 7 (02): : 428 - 428
  • [9] SUNITINIB GLOBAL EXPANDED-ACCESS TRIAL IN METASTATIC RENAL CELL CARCINOMA (MRCC) - FINAL RESULTS
    Gore, M. E.
    Porta, C.
    Bracarda, S.
    Bjarnason, G. A.
    Oudard, S.
    Lee, S.
    Crino, L.
    Kim, T. M.
    Fly, K.
    Szczylik, C.
    ANNALS OF ONCOLOGY, 2012, 23 : 271 - 271
  • [10] Sunitinib expanded-access trial in metastatic renal cell carcinoma (mRCC) - final US results
    Hutson, T. E.
    Dudek, A. Z.
    Fishman, M. N.
    Thompson, J. A.
    Agarwal, N.
    George, D. J.
    Zhang, K.
    Fly, K.
    Matczak, E.
    Lechuga, M. J.
    Dreicer, R.
    BJU INTERNATIONAL, 2013, 112 : 4 - 5
12345